Vanderbilt-Ingram Cancer Center
- VICC Home
- Wellness, Support
and Prevention - Patient Guide
for Cancer - Cancer Types
and Treatments - Meet Our
Team - Locations
and Services - Clinical Trials
Myeloproliferative Disorders
Myeloproliferative disorders cause the bone marrow to make too many red blood cells, white blood cells or platelets.
The bone marrow normally makes blood stem cells (immature cells) that develop into mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell, which develops into a white blood cell.
Myeloproliferative disorders make too many blood stem cells that develop into one or more types of blood cells. As the number of extra blood cells rises, the disorders can get worse.
There are 6 types of chronic myeloproliferative disorders:
-
Chronic myelogenous leukemia
- Polycythemia vera: Disease causing the blood thicken with too many red blood cells in the blood and bone marrow
- Primary myelofibrosis (also called chronic idiopathic myelofibrosis): Chronic disease that replaces the bone marrow with fibrous tissue. Organs such as the liver and spleen begin to make blood; normally bone marrow does this.
- Essential thrombocythemia: High number of thrombocytes, or platelets, in the blood
- Chronic neutrophilic leukemia: Too many neutrophils (a type of white blood cell) in the blood
- Chronic eosinophilic leukemia: Too many eosinophils (a type of white blood cell) in the bone marrow, blood and other tissues
Chronic myeloproliferative disorders sometimes become acute leukemia when too many abnormal white blood cells are made.
Diagnosis
These tests can help detect and diagnose myeloproliferative disorders:
- Physical exam and history
-
Complete blood count (CBC) checks for the following:
-Number of red blood cells and platelets
-Number and type of white blood cells
-Amount of hemoglobin (the protein that carries oxygen) in the red blood cells
-Portion of the sample made up of red blood cells - Peripheral blood smear: Blood is checked for blast (developing) cells, number and kind of white blood cells, number of platelets and shape changes of blood cells
- Bone marrow aspiration and biopsy: Removal of bone marrow, blood and a small piece of bone using a needle
- Cytogenetic analysis: Lab test used to see chromosomal changes from tissue cells
Symptoms
Symptoms of Juvenile Myelomonocytic Leukemia:
- Pale complexion
- Fever
- Infection
- Easy bleeding
- A cough
- Poor weight gain
- Skin rash
- Swollen lymph nodes
Symptoms of Chronic Myelomonocytic Leukemia:
- Fever
- Infection
- Fatigue
- Easy bruising or bleeding
- Pain or a feeling of fullness below the ribs
Symptoms of Atypical Chronic Myelogenous Leukemia:
- Easy bruising or bleeding
- Fatigue
- Shortness of breath
- Pale complexion
- Pinpoint-sized spots under the skin from bleeding
- Pain or a feeling of fullness below the ribs on the left side
Treatment
There are many treatment options available, including chemotherapy, radiation, blood transfusion therapy, surgery, biologic therapy and stem cell transplants.
Treatment options depend on:
- Whether the myeloprofilerative disorder occurred after chemotherapy for another disease
- Whether the myeloprofilerative disorder has gotten worse after treatment
- Patient’s age and general health
If you are diagnosed with any of these conditions, talk to your doctor about joining a clinical trial.
Risk Factors
- Previous chemotherapy treatment
- Genetic syndromes
- Smoking
- Being older than 60
- Being male
Related Links
Vanderbilt-Ingram Cancer Center
National Cancer Institute
American Cancer Society
The Leukemia & Lymphoma Society
Vanderbilt University Medical Center Main Number: 615-322-5000
The information provided on this site is designed to support, not replace, the relationship that exists between you and your existing physician or healthcare provider. Please contact your physician or healthcare provider for specific medical advice and/or treatment recommendations.
Links contained in this Web site to information provided by other organizations are presented as a service and neither constitutes nor implies Vanderbilt University Medical Center's endorsement or warranty.


Find Us On: